143 related articles for article (PubMed ID: 6498831)
1. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes.
Marre F; Fabre G; Lacarelle B; Bourrie M; Catalin J; Berger Y; Rahmani R; Cano JP
Drug Metab Dispos; 1992; 20(2):316-21. PubMed ID: 1352227
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.
McManus ME; Burgess WM; Veronese ME; Huggett A; Quattrochi LC; Tukey RH
Cancer Res; 1990 Jun; 50(11):3367-76. PubMed ID: 2334931
[TBL] [Abstract][Full Text] [Related]
4. Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys. Correlations with aryl hydrocarbon hydroxylase activities.
Juchau MR; Namkung MJ; Berry DL; Zachariah PK
Drug Metab Dispos; 1975; 3(6):493-501. PubMed ID: 1224
[TBL] [Abstract][Full Text] [Related]
5. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
Fleming CM; Branch RA; Wilkinson GR; Guengerich FP
Mol Pharmacol; 1992 May; 41(5):975-80. PubMed ID: 1588928
[TBL] [Abstract][Full Text] [Related]
6. Sequence requirements for cytochrome P-450IID1 catalytic activity. A single amino acid change (Ile380 Phe) specifically decreases Vmax of the enzyme for bufuralol but not debrisoquine hydroxylation.
Matsunaga E; Zeugin T; Zanger UM; Aoyama T; Meyer UA; Gonzalez FJ
J Biol Chem; 1990 Oct; 265(28):17197-201. PubMed ID: 1976628
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
[TBL] [Abstract][Full Text] [Related]
8. Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.
Wolff T; Deml E; Wanders H
Drug Metab Dispos; 1979; 7(5):301-5. PubMed ID: 40770
[TBL] [Abstract][Full Text] [Related]
9. Suppressive role of indole on 2-acetylaminofluorene hepatotoxicity.
Hopp ML; Matsumoto M; Wendell B; Lee C; Oyasu R
Cancer Res; 1976 Jan; 36(1):234-9. PubMed ID: 1248002
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans.
Holsztynska EJ; Weber WW; Domino EF
Drug Metab Dispos; 1991; 19(1):48-53. PubMed ID: 1673421
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450IID subfamily in non-human primates. Catalytical and immunological characterization.
Jacqz-Aigrain E; Gueguen M; Zanger UM; Robieux I; Alvarez F
Biochem Pharmacol; 1991 Jun; 41(11):1657-63. PubMed ID: 2043154
[TBL] [Abstract][Full Text] [Related]
12. Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6.
Kronbach T
Methods Enzymol; 1991; 206():509-17. PubMed ID: 1686064
[No Abstract] [Full Text] [Related]
13. Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
Blanck A; Hällström IP; Eriksson LC
Carcinogenesis; 1990 Jul; 11(7):1067-73. PubMed ID: 2372866
[TBL] [Abstract][Full Text] [Related]
14. Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane.
Surbrook SE; Olson MJ
Drug Metab Dispos; 1992; 20(4):518-24. PubMed ID: 1356728
[TBL] [Abstract][Full Text] [Related]
15. [Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone].
Boriani G; Capucci A; Strocchi E; Marchesini B; Baroni M; Frabetti L; Ambrosioni E; Magnani B
G Ital Cardiol; 1991 May; 21(5):517-26. PubMed ID: 1936756
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes.
Wolff T; Strecker M
Exp Toxicol Pathol; 1992 Sep; 44(5):263-71. PubMed ID: 1446164
[TBL] [Abstract][Full Text] [Related]
17. The specificity and multiplicity of human placental xenobiotic-metabolizing monooxygenase system studied by potential substrates, inhibitors and gel electrophoresis.
Pelkonen O; Moilanen ML
Med Biol; 1979 Oct; 57(5):306-12. PubMed ID: 522518
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
Lu XL; Guengerich FP; Yang SK
Drug Metab Dispos; 1991; 19(3):637-42. PubMed ID: 1680631
[TBL] [Abstract][Full Text] [Related]
19. Drug metabolism in rats with cancer induced by N-nitrosodiethylamine and phenobarbital.
Aitio ML; Hietanen E; Béréziat JC; Arvela P; Bartsch H
Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):468-74. PubMed ID: 1438025
[TBL] [Abstract][Full Text] [Related]
20. Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis.
Toutoungi M; Magnenat D
Eur J Clin Pharmacol; 1990; 38(6):633-4. PubMed ID: 2373140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
